Ray Co

Ray Co FCF Yield

The Free Cash Flow Yield of Ray Co (228670.KQ) as of Nov 18, 2026 is 10.95 %. In the previous year, Free Cash Flow Yield was -3.43 % — a change of -419.19% (higher).

FCF Yield

10.95 %

YoY

-419.19%

Last updated:

Free Cash Flow Yield of Ray Co is 2025 10.95 % . Free Cash Flow Yield of Ray Co was 2024 -3.43 % . It decreases by -419.19% higher compared to the previous year.

The Ray Co FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
2.39 KRW
Jan 1, 2019
5.63 KRW
Jan 1, 2020
-2.28 KRW
Jan 1, 2021
-14.52 KRW
Jan 1, 2022
-48.59 KRW
Jan 1, 2023
-30.20 KRW
Jan 1, 2024
-3.43 KRW
Jan 1, 2025
10.95 KRW
The Ray Co FCF Yield history
YEARFCF YieldYoY
10.95 %-419.19%
-3.43 %-88.64%
-30.20 %-37.85%
-48.59 %+234.68%
-14.52 %+537.09%
-2.28 %-140.46%
5.63 %+136.02%
2.39 %-214.35%
-2.09 %-14.23%
-2.43 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ray Co Stock analysis

What does Ray Co do? Ray Co., Ltd. generates revenue through the manufacturing and sale of advanced technology medical devices, focusing on digital diagnostic systems and digital therapy solutions. The company produces dental radiography equipment such as x-ray systems and cone beam computed tomography (CBCT) systems, alongside 3D scanning, dental computer aided design (CAD), and 3D printers for prosthodontics, orthodontics, and implant surgery. Domestic and overseas markets purchase these products, with the company operating through subsidiaries to distribute its offerings globally. Digital diagnostic systems like dental radiography equipment and CBCT systems are sold to healthcare providers and dental clinics, while digital therapy solutions including 3D scanning and CAD systems target dental laboratories and surgical centers. The firm's product portfolio serves both domestic and international clients, leveraging its subsidiaries for global distribution channels. Ray Co., Ltd. emphasizes advanced technology in its medical device offerings, with digital therapy solutions such as 3D printers and CAD systems being key revenue drivers. The company's focus on dental-specific applications ensures targeted sales to specialized healthcare segments, including prosthodontics, orthodontics, and implant surgery practices. Ray Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ray Co stock

Free Cash Flow Yield of Ray Co is 10.95 % in 2025.

Free Cash Flow Yield of Ray Co changed from -3.43 % to 10.95 %, representing a -419.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Ray Co since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Ray Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Ray Co

All Key Metrics — Ray Co